VEGFA and congestive heart failure: As a result, patients with the homozygous CHF Y402H genotype (CC) and, to a much lesser extent, patients with the heterozygous genotype (CT) are likely to have a less favorable response to anti-VEHF treatment, and may require additional applications or switching to different anti-VEGF agents.